The fragment based drug discovery platform searches for small molecular "fragments" that bind to the target biological macromolecule. Fragments offer a possibility of exploring much broader chemical combinatorial space that conventional HTS campaigns at a fraction of cost. We use newest NMR equipment to accurately determine weak interactions between fragment and target macromolecule.
600 MHz spectrometer for fragment-based screening; Source: Grzegorz Popowicz
Our facility is able to screen libraries of several thousands of molecules in few days using fully automated sample preparation and measurement system.
Robot for sample preparation; Source: Grzegorz Popowicz